Unitedhealth Group Intrinsic Value Calculator – UnitedHealth Group Stock Falls Behind Competitors on Wednesday

December 23, 2023

🌥️Trending News

UNITEDHEALTH ($NYSE:UNH): On Wednesday, UnitedHealth Group Inc. experienced a dip in stock performance compared to its competitors. UnitedHealth Group Inc. is an American for-profit managed health care company that provides health care products and insurance services. It is the largest healthcare company in the world and one of the largest companies in the United States by total revenue. The company operates in multiple countries, primarily in the United States, and is the largest single health carrier in the United States. The company offers a range of services for employers, government programs, individuals, and families. It has managed care plans, health care solutions and related services, and health care products for individuals and families.

The company also offers health benefits to individuals and families through its Medicare and Medicaid plans. The company also provides a variety of services to employers, including benefits administration, health plan management, and pharmacy benefit management services. UnitedHealth Group Inc. stock has generally performed well over time but on Wednesday it experienced a dip in performance compared to its competitors. This could be attributed to a number of factors including changes in the market, economic uncertainty, or simply investor sentiment. Despite this recent dip, investors may still see value in investing in this stock as it has historically performed well over time.

Price History

The stock opened at $518.9 and closed at $519.9, representing a 0.8% increase from the previous closing price of $515.9. This was in stark contrast to the performances of other healthcare stocks such as Anthem, Cigna, and Humana, who experienced a notable increase in their stock prices on the same day. Despite the small increase in the stock’s value, UnitedHealth Group fell behind its competitors in terms of overall performance. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Unitedhealth Group. More…

    Total Revenues Net Income Net Margin
    359.98k 21.69k 6.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Unitedhealth Group. More…

    Operations Investing Financing
    29.73k -29.76k 19
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Unitedhealth Group. More…

    Total Assets Total Liabilities Book Value Per Share
    282.06k 188.08k 96.69
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Unitedhealth Group are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    12.5% 9.6% 8.8%
    FCF Margin ROE ROA
    7.3% 22.9% 7.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Unitedhealth Group Intrinsic Value Calculator

    At GoodWhale, we have conducted an analysis of UNITEDHEALTH GROUP‘s fundamentals and we are pleased to report that the stock is currently undervalued by 5.4%. Our proprietary Valuation Line has calculated the fair value of UNITEDHEALTH GROUP’s share to be around $549.7, while the stock is traded at $519.9. This means that now is a good time to invest in UNITEDHEALTH GROUP. With our analysis, you can rest assured that you are making a sound investment decision. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    One of the largest health insurance providers in the United States is UnitedHealth Group Inc. They offer a wide variety of health insurance plans and are always looking for new ways to provide the best possible service to their customers. Some of their main competitors are Humana Inc, CVS Health Corp, and Centene Corp. Although all of these companies are very different, they all share one common goal: to provide their customers with the best health insurance coverage possible.

    – Humana Inc ($NYSE:HUM)

    Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky. As of 2019, Humana has had over 13 million customers in the United States. The company’s revenue was US$54.4 billion in 2018.

    – CVS Health Corp ($NYSE:CVS)

    CVS Health Corp is a leading provider of healthcare services in the United States. The company has a market capitalization of $120.33 billion as of 2022 and a return on equity of 10.96%. The company operates more than 9,700 retail pharmacies, over 1,100 walk-in medical clinics, and a leading pharmacy benefits manager with more than 77 million members. CVS Health Corp is dedicated to helping people on their path to better health by providing them with the resources they need to make informed decisions about their health and wellbeing.

    – Centene Corp ($NYSE:CNC)

    Centene Corporation is a large publicly traded managed care organization. The company’s core business is Medicaid managed care, but it also offers Medicare, long-term care, dental, behavioral health, and vision plans. The company serves over 25 million members in 26 states and the District of Columbia.

    Centene’s market cap of $43.28 billion and ROE of 6.97% indicate that it is a large and successful company. The company’s size and success are due in part to its focus on Medicaid managed care. Medicaid is a government health insurance program for low-income Americans. Centene has been able to grow its Medicaid business by providing high-quality care at a lower cost than its competitors.

    Summary

    UnitedHealth Group Inc. (UNH) is a diversified healthcare company that covers medical services, technology, and health insurance. On Wednesday, UNH’s stock underperformed compared to its competitors. Analysts point to macroeconomic factors such as increasing labor costs and a stagnant US economy as potential issues for investors to consider. Short-term investors have been cautious due to the uncertainty surrounding US economic growth and the impact of the coronavirus pandemic on the healthcare industry.

    Long-term investors have been encouraged by UNH’s consistent revenue growth, its strong balance sheet, and its wide array of health services and technologies. Analysts have also noted that the company’s dividend yield of nearly 2% is an attractive long-term investment. Despite the short-term uncertainty, UNH remains a solid choice for investors looking for a dependable healthcare stock.

    Recent Posts

    Leave a Comment